Sweden · Delayed Price · Currency is SEK Coegin Pharma AB Statistics
Total Valuation
NGM:COEGIN has a market cap or net worth of SEK 124.89 million. The enterprise value is 117.52 million.
| Market Cap | 124.89M |
| Enterprise Value | 117.52M |
Important Dates
The last earnings date was Thursday, November 20, 2025.
| Earnings Date | Nov 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NGM:COEGIN has 24.88 million shares outstanding. The number of shares has increased by 85.15% in one year.
| Current Share Class | 24.88M |
| Shares Outstanding | 24.88M |
| Shares Change (YoY) | +85.15% |
| Shares Change (QoQ) | +1.95% |
| Owned by Insiders (%) | 11.72% |
| Owned by Institutions (%) | 14.44% |
| Float | 17.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 10.72 |
| P/TBV Ratio | 16.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.69 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.40 |
Financial Position
The company has a current ratio of 4.36
| Current Ratio | 4.36 |
| Quick Ratio | 3.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,884.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -178.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -6.88M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.53% in the last 52 weeks. The beta is 1.27, so NGM:COEGIN's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | +35.53% |
| 50-Day Moving Average | 6.60 |
| 200-Day Moving Average | 4.74 |
| Relative Strength Index (RSI) | 33.29 |
| Average Volume (20 Days) | 34,327 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -16,000 |
| Operating Income | -20.73M |
| Pretax Income | -20.64M |
| Net Income | -20.64M |
| EBITDA | -17.71M |
| EBIT | -20.73M |
| Earnings Per Share (EPS) | -0.80 |
Balance Sheet
The company has 7.37 million in cash and n/a in debt, giving a net cash position of 7.37 million or 0.30 per share.
| Cash & Cash Equivalents | 7.37M |
| Total Debt | n/a |
| Net Cash | 7.37M |
| Net Cash Per Share | 0.30 |
| Equity (Book Value) | 11.65M |
| Book Value Per Share | 0.47 |
| Working Capital | 7.54M |
Cash Flow
In the last 12 months, operating cash flow was -18.22 million and capital expenditures -124,000, giving a free cash flow of -18.35 million.
| Operating Cash Flow | -18.22M |
| Capital Expenditures | -124,000 |
| Free Cash Flow | -18.35M |
| FCF Per Share | -0.74 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NGM:COEGIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -85.15% |
| Shareholder Yield | -85.15% |
| Earnings Yield | -16.53% |
| FCF Yield | -14.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 15, 2023. It was a reverse split with a ratio of 0.01.
| Last Split Date | Jun 15, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |